Snowball logo
logo
SANN

Santhera Pharmaceuticals Holding AG

SANN SW
Fr16.00+Fr0.12  (0.76%)
Estimate
EPS
-3.78
Beta
-0.276
Forecast
P/E (FWD)
94.1
EPS (FWD)
0.17
About the company
Ticker
SANN
ISIN
CH0027148649
Country
Switzerland
Sector (GICS)
Healthcare
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.

Frequently asked questions

What sector does Santhera Pharmaceuticals Holding AG (SANN) operate in?

Santhera Pharmaceuticals Holding AG belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Santhera Pharmaceuticals Holding AG (SANN) current stock price?

As of the latest data, Santhera Pharmaceuticals Holding AG stock price is CHF 16.00, with a previous close of CHF 15.88. Santhera Pharmaceuticals Holding AG gained CHF 0.12 in the last trading session, representing a 0.76% increase.

What is Santhera Pharmaceuticals Holding AG (SANN) current market capitalization?

Santhera Pharmaceuticals Holding AG market cap is approximately 237.30 million.

What is Santhera Pharmaceuticals Holding AG (SANN) Earnings Per Share (EPS)?

The trailing EPS is -CHF 3.78, and the forward EPS is CHF 0.17.

Does Santhera Pharmaceuticals Holding AG (SANN) pay dividends?

No. Santhera Pharmaceuticals Holding AG does not pay a dividend.

When is Santhera Pharmaceuticals Holding AG (SANN) next earnings report?

Santhera Pharmaceuticals Holding AG is expected to release its next earnings report on December 31, 2025.

What is Santhera Pharmaceuticals Holding AG (SANN) beta (volatility) score?

Santhera Pharmaceuticals Holding AG has a beta of -0.276, indicating lower volatility than the overall market.